Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
NCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 06554795 Brief Summary A Phase 1/2a First-in-Human Study of DB-1419 in…
Read more arrow_forwardNCT 06824155 Brief Summary This is a first-in-human, Phase 0/1, open-label study…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 06097728 Brief Summary This is a phase III, randomized, open-label, multicenter,…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forward